Identifying cases of undiagnosed, clinically significant COPD in primary care: Qualitative insight from patients in the target population

npj Primary Care Respiratory Medicine

Volumn 25, Issue , 2015, Pages

  Leidy, Nancy K ^a   Kim, Katherine ^b   Bacci, Elizabeth D ^c   Yawn, Barbara P ^d   Mannino, David M ^e   Thomashow, Byron M ^f   Barr, R Graham ^g   Rennard, Stephen I ^h   Houfek, Julia F ⁱ   Han, Meilan K ^a   Meldrum, Catherine A ^a   Make, Barry J ^a   Bowler, Russ P ^c   Steenrod, Anna W ^d   Murray, Lindsey T ^e   Walsh, John W ^a   Martinez, Fernando ^a  

^a EVIDERA   (United States)

^b OLMSTED MEDICAL CENTER   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g DEPARTMENT OF MEDICINE   (United States)

^h National Bronchiectasis Research Registry   (United States)

ⁱ WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CHEST INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FAMILY HISTORY; FEMALE; HOSPITALIZATION; HUMAN; MALE; OBESITY; PASSIVE SMOKING; PEAK EXPIRATORY FLOW; PRIMARY MEDICAL CARE; QUALITATIVE ANALYSIS; RESPIRATORY FLOWMETER; RISK FACTOR; SMOKING; TELEPHONE INTERVIEW; AGED; HEALTH STATUS; MIDDLE AGED; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITATIVE RESEARCH; SPIROMETRY;

AGED; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITATIVE RESEARCH; RISK FACTORS; SMOKING; SPIROMETRY;

EID: 84937053938     PISSN: None     EISSN: 20551010     Source Type: Journal    
DOI: 10.1038/npjpcrm.2015.24     Document Type: Article

References (44)

1. Mathers CD, Loncar D. Projections of global mortality and burDen of disease from 2002 to 2030. PLoS Med 2006; 3: e442
2. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008; 63: 402-407
3. Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest 2013; 143: 1395-1406
4. Gruffydd-Jones K, Loveridge C. The 2010 NICE COPD guidelines: how do they compare with the GOLD guidelines? Prim Care Respir J 2011; 20: 199-204
5. Postma D, Anzueto A, Calverley P, Jenkins C, Make B, Sciurba F et al. A new perspective on optimal care for patients with COPD. Prim Care Respir J 2011; 20: 205-209
6. Wilt T, Niewoehner D, MacDonald R, Kane R. Management of stable chronic obstructive pulmonary disease: A systematic review for a clinical practice guideline. Ann Int Med 2007; 147: 639-653
7. Donaldson GC, Seemungal TA, Patel IS, Lloyd-Owen SJ, Wilkinson TM, Wedzicha JA. Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J 2003; 22: 931-936
8. Halpin DM, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP. Exacerbation frequency and course of COPD. Int J Chron Obstruct Pulmon Dis 2012; 7: 653-661
9. Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P et al. Changes in forced expiratory volume in 1 s over time in COPD. N Engl J Med 2011; 365: 1184-1192
10. Bourbeau J, Ford G, Zackon H, Pinsky N, Lee J, Ruberto G. Impact on patients' health status following early iDentification of a COPD exacerbation. Eur Respir J 2007; 30: 907-913
11. Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Wang C et al. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year. Eur Respir J 2010; 35: 1022-1030
12. Anzueto A, Sethi S, Martinez FJ. Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4: 554-564
13. Hurst J, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128-1138
14. Bastin AJ, Starling L, Ahmed R, Dinham A, Hill N, Stern M et al. High prevalence of undiagnosed and severe chronic obstructive pulmonary disease at first hospital admission with acute exacerbation. Chron Respir Dis 2010; 7: 91-97
15. Tinkelman DG, Price D, Nordyke RJ, Halbert RJ. COPD screening efforts in primary care: what is the yield? Prim Care Respir J 2007; 16: 41-48
16. Minas M, Hatzoglou C, Karetsi E, Papaioannou AI, Tanou K, Tsaroucha R et al. COPD prevalence and the differences between newly and previously diagnosed COPD patients in a spirometry program. Prim Care Respir J 2010; 19: 363-370
17. Mapel DW, Dalal AA, Blanchette CM, Petersen H, Ferguson GT. Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims. Int J Chron Obstruct Pulmon Dis 2011; 6: 573-581
18. Gao Y, Hou Q, Wang H. Assessment of health status in patients with newly diagnosed chronic obstructive pulmonary disease. PLoS One 2013; 8: e82782
19. Roche N, Gaillat J, Garre M, Meunier J, Lemaire N, Bendjenana H. Acute respiratory illness as a trigger for detecting chronic bronchitis in adults at risk of COPD: A primary care survey. Prim Care Respir J 2010; 19: 371-377
20. van Schayck C, Loozen J, Wagena E, Akkermans R, Wesseling G. Detecting patients at high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ 2002; 324: 1370-1375
21. Freeman D, Nordyke R, Isonaka S, Nonikov V, Maroni J, Price D et al. Questions for COPD diagnostic screening in a primary care setting. Respir Med 2005; 99: 1311-1318
22. Price D, Tinkelman D, Halbert R, Nordyke R, Isonaka S, Nonikov D et al. Symptombased questionnaire for iDentifying chronic obstructive pulmonary disease in smokers. Respiration 2006; 73: 285-295
23. Tinkelman D, Price D, Nordyke R, Halbert R, Isonaka S, Nonikov D et al. Symptombased questionnaire for differentiating COPD and asthma. Respiration 2006; 73: 296-305
24. Price D, Tinkelman D, Nordyke R, Isonaka S, Halbert Rfor the COPD Questionnaire Study Group. Scoring system and clininical application of COPD diagnostic questionnaires. Chest 2006; 129: 1531-1539
25. Kotz D, Nelemans P, van Schayck C, Wesseling G. External validation of a COPD diagnostic questionnaire. Eur Respir J 2008; 31: 298-303
26. Martinez F, Raczek A, Seifer F, Conoscenti C, Colice T, D'Eletto T et al. Development and initial validation of a self-scored COPD population screener questionnaire (COPD-PS). COPD 2008; 5: 85-95
27. Yawn B, Mapel D, Mannino D, Martinez F, Donohue J, Hanania N et al. Development of the Lung Function Questionnaire (LFQ) to iDentify airflow obstruction. Int J Chron Obstruct Pulmon Dis 2010; 5: 1-10
28. Hanania N, Mannino D, Yawn B, Mapel D, Martinez F, Donohue J et al. Predicting risk of airflow obstruction in primary care: validation of the lung function questionnaire (LFQ). Respir Med 2010; 104: 1160-1170
29. Frith P, Crockett A, Beilby J, Marshall D, Attewell R, Ratnanesan A et al. Simplified COPD screening: validation of the Piko-6 in primary care. Prim Care Respir J 2011; 20: 190-198
30. Sichletidis L, Spyratos D, Papaioannou M, Chloros D, Tsiotsios A, Tsagaraki V et al. A combination of the IPAG questionnaire and Piko-6 flow meter is a valuable screening tool for COPD in the primary care setting. Prim Care Respir J 2011; 20: 184-189
31. Jithoo A, Enright PL, Burney P, Buist AS, Bateman ED, Tan WC et al. Case-finding options for COPD: results from the BurDen of Obstructive Lung Disease study. Eur Respir J 2013; 41: 548-555
32. Nelson SB, LaVange LM, Nie Y, Walsh JW, Enright PL, Martinez FJ et al. Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. Chest 2012; 142: 358-366
33. Martinez FJ. NHLBI Workshop: A Case-finding Strategy for Moderate-to-Severe COPD in the United States Executive Summary. November 2009. http://www.nhlbi.nih.gov/research/reports/2009-case-finding-exesum.htm. Accessed 6 November 2014
34. Han M, Steenrod A, Dansie EJ, Leidy N, Mannino D, Thomashow BM et al. IDentifying patients with undiagnosed COPD in primary care settings: insight from screening tools and epidemiologic studies. J COPD F (in press
35. Leidy N, Malley K, Steenrod A, Mannino D, Make B, Bowler R et al. IDentifying best variables for COPD case iDentification in primary care: A random forests analysis (under review
36. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management and prevention of COPD. 2014. http://www.goldcopd. org. Accessed 6 November 2014
37. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483
38. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34: 648-654
39. Fromer L. Diagnosing and treating COPD: understanding the challenges and finding solutions. Int J Gen Med 2011; 4: 729-739
40. Walters JA, Walters EH, Nelson M, Robinson A, Scott J, Turner P et al. Factors associated with misdiagnosis of COPD in primary care. Prim Care Respir J 2011; 20: 396-402
41. Lindgren S, Storli SL, Wiklund-Gustin L. Living in negotiation: patients' experiences of being in the diagnostic process of COPD. Int J Chron Obstruct Pulmon Dis 2014; 9: 441-451
42. Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E et al. COPD in never smokers: results from the population-based burDen of obstructive lung disease study. Chest 2011; 139: 752-763
43. Celli BR, Halbert RJ, Nordyke RJ, Schau B. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. Am J Med 2005; 118: 1364-1372
44. Kon SS, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ et al. Minimum clinically important difference for the COPD Assessment Test: A prospective analysis. Lancet Respir Med 2014; 2: 195-203